Refine by MP, party, committee, province, or result type.
Industry committee I would add that I think one critical element that is really now starting to gel is our working together. This is essential, because actually the balance will come from our working together and ensuring that the resources are put in the right place.
April 17th, 2008Committee meeting
Dr. Pierre Chartrand
Industry committee The capacity to capture the excellence is the most crucial criterion, because at the end of the day, if we're talking about research and training, it's all about people. So our capacity to capture that excellence is critical.
April 17th, 2008Committee meeting
Dr. Pierre Chartrand
Industry committee Absolutely. Actually, they're programs that are managed by the same steering committee. Of the committees reviewing the proposals, one of them is the same for both. So they are really aligned one with another.
April 17th, 2008Committee meeting
Dr. Pierre Chartrand
Industry committee I am sorry to tell you that I have a great fear of accepting the notion of Canadian mediocrity in research. All our indicators show that our research performance is very high, both in the number of discoveries and in their impact. I agree about the number of Nobel prizes won by
April 17th, 2008Committee meeting
Dr. Pierre Chartrand
Industry committee Actually, the returns linked to intellectual property go to the institutions. The universities, which for the most part are public institutions, are the ones who benefit from the discoveries or the research.
April 17th, 2008Committee meeting
Dr. Pierre Chartrand
Industry committee As Dr. Gaffield mentioned, for us, the process goes in a cycle. Researchers are encouraged to make discoveries and the institutes seek to protect the intellectual property associated with those discoveries. Any benefits from that will have economic effects on the population that
April 17th, 2008Committee meeting
Dr. Pierre Chartrand
Industry committee We are not-for-profit organizations.
April 17th, 2008Committee meeting
Dr. Pierre Chartrand
Industry committee I think it is very important to foster the interest at the secondary level and even before that. We have a program called Synapse. It's a mentoring program; the researchers in particular are very keen in doing that part of the mentoring. I think we need to tap into these people
April 17th, 2008Committee meeting
Dr. Pierre Chartrand
Industry committee In the area of health, I would say that there are clear economic benefits. Think of the development of biotechnology and the pharmaceutical industry in Canada. Those are what I would categorize as classic economic impacts. In commercialization, the health sector is very active.
April 17th, 2008Committee meeting
Dr. Pierre Chartrand
Industry committee I would add a comment to that. Certainly very important in health research and the other areas too is that we need to be in line with...because knowledge translation involves the application of the results. In health that is largely dependent on the provinces, so we really need
April 17th, 2008Committee meeting
Dr. Pierre Chartrand
Industry committee SARS is another example. We needed to have the preparedness, but we couldn't predict in advance that we'd have the problem.
April 17th, 2008Committee meeting
Dr. Pierre Chartrand
Industry committee Yes. The three councils, and I include the Canadian Foundation for Innovation, are making great efforts to put in place programs to encourage the development of careers for women in science, in research and in human sciences. The issue is not necessarily about support at the be
April 17th, 2008Committee meeting
Dr. Pierre Chartrand
Industry committee The programs that Canada has put in place in recent years make us competitive. Before I joined CIHR, I had the privilege of setting up a new research institute at the Université de Montréal. Because of programs established quite recently, we were able to attract a number of team
April 17th, 2008Committee meeting
Dr. Pierre Chartrand
Industry committee Exactly.
April 17th, 2008Committee meeting
Dr. Pierre Chartrand
Industry committee Currently in the U.S. the success rate is very low. It has been extremely low over the last few years. I can give you the number of successful applications in terms of the overall applications. It would vary, but it is somewhere between 10% to 15%, depending on the panels. I ca
April 17th, 2008Committee meeting
Dr. Pierre Chartrand